Increased expression of T cell immunoglobulin- and mucin domain-containing molecule-3 on natural killer cells in atherogenesis

Atherosclerosis

Volumn 222, Issue 1, 2012, Pages 67-73

  Hou, Nan ^a   Zhao, Di ^a   Liu, Ying ^a   Gao, Lifen ^a   Liang, Xiaohong ^a   Liu, Xiao ^a   Gai, Xiaoxiao ^a   Zhang, Xiaoning ^a   Zhu, Faliang ^a   Ni, Mei ^b   Zhang, Yun ^b   Sun, Wensheng ^a   Ma, Chunhong ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Atherosclerosis; NK cells; Tim 3

Indexed keywords

C REACTIVE PROTEIN; CELL MARKER; LIPID; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN CONTAINING PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CELL COUNT; CELL LOSS; CELL PROTECTION; CONTROLLED STUDY; CORRELATIONAL STUDY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

ADULT; AGED; APOPTOSIS; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FEMALE; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; MALE; MEMBRANE PROTEINS; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862789324     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.02.009     Document Type: Article

References (29)

1. Hansson G.K. Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001, 21:1876-1890.
2. Hansson G.K., Libby P., Schonbeck U., et al. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002, 91:281-291.
3. Shi F.D., Van Kaer L. Reciprocal regulation between natural killer cells and autoreactive T cells. Nat Rev 2006, 6:751-760.
4. Shi F.D., Zhou Q. Natural killer cells as indispensable players and therapeutic targets in autoimmunity. Autoimmunity 2011, 44:3-10.
5. Bobryshev Y.V., Lord R.S. Identification of natural killer cells in human atherosclerotic plaque. Atherosclerosis 2005, 180:423-427.
6. Millonig G., Malcom G.T., Wick G. Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study. Atherosclerosis 2002, 160:441-448.
7. Whitman S.C., Rateri D.L., Szilvassy S.J., et al. Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice. Arterioscler Thromb Vasc Biol 2004, 24:1049-1054.
8. Jonasson L., Backteman K., Ernerudh J. Loss of natural killer cell activity in patients with coronary artery disease. Atherosclerosis 2005, 183:316-321.
9. Sabatos C.A., Chakravarti S., Cha E., et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 2003, 4:1102-1110.
10. Zhu C., Anderson A.C., Schubart A., et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005, 6:1245-1252.
11. Anderson A.C., Anderson D.E., Bregoli L., et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 2007, 318:1141-1143.
12. Khademi M., Illés Z., Gielen A.W., et al. T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol 2004, 172:7169-7176.
13. Ju Y., Hou N., Meng J., et al. T cell immunoglobulin and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol 2010, 52:322-329.
14. Grund E.M., Muise-Helmericks R.C. Cost efficient and effective gene transfer into the human natural killer cell line, NK92. J Immunol Methods 2005, 296:31-36.
15. Oikawa T., Kamimura Y., Akiba H., et al. Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease. J Immunol 2006, 177:4281-4287.
16. Stokes K.Y. Microvascular responses to hypercholesterolemia: the interactions between innate and adaptive immune responses. Antioxid Redox Signal 2006, 8:141-151.
17. Stokes K.Y., Cooper D., Tailor A., et al. Hypercholesterolemia promotes inflammation and microvascular dysfunction: role of nitric oxide and superoxide. Free Radical Biol Med 2002, 33:1026-1036.
18. Aviram M. Hyperlipidaemia and cardiovascular disease: inflammation and oxidative stress in diabetic patients. Curr Opin Lipidol 2009, 20:258-259.
19. Wang Y., Ding T.L., Zhang L.L., et al. Clinical significance of inflammatory reaction in patients with coronary heart disease. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2003, 19:467-468.
20. Kostner K.M., Fahti R.B., Case C., et al. Inflammation, complement activation and endothelial function in stable and unstable coronary artery disease. Clin Chim Acta 2006, 365:129-134.
21. Li W., Lidebjer C., Yuan X.M., et al. NK cell apoptosis in coronary artery disease relation to oxidative stress. Atherosclerosis 2008, 199:65-72.
22. De Sanctis J.B., Blanca I., Bianco N.E. Secretion of cytokines by natural killer cells primed with interleukin-2 and stimulated with different lipoproteins. Immunology 1997, 90:526-533.
23. Kinlay S., Egido J. Inflammatory biomarkers in stable atherosclerosis. Am J Cardiol 2006, 98:S2-S8.
24. Ross M.E., Caligiuri M.A. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response. Blood 1997, 89:910-918.
25. Ortald J.R., Mason A.T., O'Shea J.J. Receptor-induced death in human natural killer cells: involvement of CD16. J Exp Med 1995, 181:339-344.
26. Ida H., Robertson M.J., Voss S., et al. CD94 ligation induces apoptosis in a subset of IL-2-stimulated NK cells. J Immunol 1997, 159:2154-2160.
27. Toborek M., Blanc E.M., Kaiser S., et al. Linoleic acid potentiates TNF-mediated oxidative stress, disruption of calcium homeostasis, and apoptosis of cultured vascular endothelial cells. J Lipid Res 1997, 38:2155-2167.
28. Pawlak K., Pawlak D., Mysliwiec M. Oxidative stress influences CC-chemokine levels in hemodialyzed patients. Nephron Physiol 2004, 96:105-112.
29. Linton M.F., Major A.S., Fazio S. Proatherogenic role for NK cells revealed. Arterioscler Thromb Vasc Biol 2004, 24:992-994.